These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38861178)

  • 1. A crossover comparison of patient satisfaction with two teriparatide regimens: primary results of the Japanese Osteoporosis Intervention Trial 06 (JOINT-06).
    Soen S; Uemura Y; Tanaka S; Takeuchi Y; Endo N; Takada J; Ikeda S; Iwamoto J; Okimoto N; Tanaka S
    J Bone Miner Metab; 2024 Jun; ():. PubMed ID: 38861178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different parameters between daily and twice-weekly teriparatide in postmenopausal women with severe osteoporosis.
    Mochizuki T; Yano K; Ikari K; Okazaki K
    J Bone Miner Metab; 2023 Mar; 41(2):220-226. PubMed ID: 36625920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing - In comparison with weekly teriparatide with bisphosphonate.
    Shigenobu K; Hashimoto T; Kanayama M; Ohha H; Yamane S
    Bone Rep; 2019 Dec; 11():100217. PubMed ID: 31440529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Year Outcomes of Daily and Twice-Weekly Teriparatide Treatment in Postmenopausal Women with Severe Osteoporosis: A Randomized Non-Blinded Prospective Study.
    Mochizuki T; Yano K; Ikari K; Okazaki K
    J Bone Metab; 2024 May; 31(2):162-168. PubMed ID: 38886973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of switching once-weekly teriparatide to denosumab in osteoporosis patients.
    Miyagi M; Fujimaki H; Naruse K; Suto K; Inoue G; Nakazawa T; Imura T; Saito W; Uchida K; Shirasawa E; Takahira N; Takaso M
    J Orthop Sci; 2019 Jan; 24(1):153-158. PubMed ID: 30146385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of treatment interruption due to patient convenience on treatment of once a week teriparatide.
    Katahira G; Akiba K; Takada J; Iba K; Yamashita T
    Osteoporos Sarcopenia; 2020 Mar; 6(1):8-14. PubMed ID: 32226827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
    Ohbayashi Y; Iwasaki A; Nakai F; Mashiba T; Miyake M
    Osteoporos Int; 2020 Mar; 31(3):577-585. PubMed ID: 31768589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a randomized trial of teriparatide followed by alendronate: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).
    Tanaka S; Mori S; Hagino H; Sugimoto T
    J Bone Miner Metab; 2020 May; 38(3):412-417. PubMed ID: 31894491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results.
    Silverman S; Miller P; Sebba A; Weitz M; Wan X; Alam J; Masica D; Taylor KA; Ruff VA; Krohn K
    Osteoporos Int; 2013 Aug; 24(8):2309-17. PubMed ID: 23404615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-weekly teriparatide improves lumbar spine BMD independent of pre-treatment BMD and bone turnover marker levels.
    Takada J; Yoshimura T; Uzawa T
    J Bone Miner Metab; 2021 May; 39(3):484-493. PubMed ID: 33389132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study.
    Migliaccio S; Resmini G; Buffa A; Fornari R; Di Pietro G; Cerocchi I; Dormi A; Gimigliano F; Mulè R; Celi M; Frigato M; Lenzi A; Tarantino U; Iolascon G; Malavolta N
    Clin Cases Miner Bone Metab; 2013 Jan; 10(1):56-60. PubMed ID: 23858313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women.
    Kong M; Zhou C; Zhu K; Zhang Y; Song M; Zhang H; Tu Q; Ma X
    Clin Interv Aging; 2019; 14():1693-1703. PubMed ID: 31631990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series.
    Yoshiga D; Yoshioka I; Habu M; Sasaguri M; Tominaga K
    Br J Oral Maxillofac Surg; 2022 Jun; 60(5):604-609. PubMed ID: 34996629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women.
    Cosman F; Lane NE; Bolognese MA; Zanchetta JR; Garcia-Hernandez PA; Sees K; Matriano JA; Gaumer K; Daddona PE
    J Clin Endocrinol Metab; 2010 Jan; 95(1):151-8. PubMed ID: 19858319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program.
    van Maren MA; Wyers CE; Driessen JHM; Visser JV; de Vries F; van de Wijdeven K; Gevers S; Lems WF; Emmelot-Vonk MH; van den Bergh JPW
    Osteoporos Int; 2019 Sep; 30(9):1837-1844. PubMed ID: 31321446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05.
    Hagino H; Sugimoto T; Tanaka S; Sasaki K; Sone T; Nakamura T; Soen S; Mori S
    Osteoporos Int; 2021 Nov; 32(11):2301-2311. PubMed ID: 34002252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients.
    Wang Z; Zhuang C; Chen W; Li Z; Li J; Lin H; Dong J
    Clin Interv Aging; 2021; 16():1789-1799. PubMed ID: 34934310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of teriparatide versus percutaneous vertebroplasty on pain relief, quality of life and cost-effectiveness in postmenopausal females with acute osteoporotic vertebral compression fracture: A prospective cohort study.
    Ma Y; Wu X; Xiao X; Ma Y; Feng L; Yan W; Chen J; Yang D
    Bone; 2020 Feb; 131():115154. PubMed ID: 31733423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis.
    Ganapathy A; Nieves JW; Keaveny TM; Cosman F
    Bone; 2023 Feb; 167():116618. PubMed ID: 36410666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone microstructure changes due to once-/twice-weekly teriparatide administration: A report of five cases using high-resolution peripheral quantitative computed tomography.
    Tsukamoto M; Okimoto N; Mori M; Yoshioka T; Asano K; Ikejiri Y; Uzawa T; Yoshimura T; Suzuki H; Yamanaka Y; Kawasaki M; Sakai A
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):301-304. PubMed ID: 34792149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.